Cholangiopancreatography, Endoscopic Retrograde, Intracranial Pressure, Ketofol, Optic Nerve Sheath Diameter, Propofol
Conditions
Keywords
Cholangiopancreatography, Endoscopic Retrograde, Intracranial Pressure, optic nerve sheath diameter, ketofol, propofol
Brief summary
Aim: To compare the effect of procedural anesthesia management with ketofol and propofol on the sonographic optic nerve sheath diameter in the endoscopic retrograde cholangiopancreatography (ERCP) procedures.
Detailed description
Adequate visualization of the gastrointestinal mucosa during endoscopic retrograde cholangiopancreatography (ERCP) requires distention of the intestinal lumen by gas insufflation. High intraluminal pressures can increase intraabdominal pressure, leading to an increase in intracranial pressure. Ultrasonographic measurement of the optic nerve sheath diameter is a simple, non-invasive, and reliable technique for assessing intracranial pressure. Propofol, a sedative-hypnotic agent with rapid onset and short duration of action, is often used.Theoretically, the combination of ketamine and propofol may maintain sedation efficacy while reducing cardiovascular side effects through dose reduction and due to its synergistic effects. The aim of this study is to demonstrate whether our anesthesia management has an effect on ICP change by measurement of optic nerve sheath diameter, predicting that insufflation performed for imaging during the ERCP procedure increase intraabdominal pressure, and frequently observed situations such as insufficient sedation, prone position, coughing and Valsalva during the procedure increase intracranial pressure (ICP).
Interventions
With the linear ultrasound probe operating at 11 MHz in B mode, it will be measured in 2 planes, 3.0 mm behind the optic disc, the transverse plane where the probe is placed horizontally and the sagittal plane where the probe is placed vertically. Then, the average of these measurements will be recorded for both eyes every 10 minutes.
Sponsors
Study design
Intervention model description
Prospective randomized double blinded study
Eligibility
Inclusion criteria
* Patients undergoing ERCP procedure * ASA score of I, II, and III
Exclusion criteria
* chronic lung disease * renal or hepatic failure * uncontrolled comorbidities (diabetes mellitus, hypertension, etc.) * central nervous system disease * pregnancy * undergoing optic nerve surgery * glaucoma or increased intraocular pressure, and retinal detachment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| optic nerve sheath diameter change among 6 time period | Baseline, immediately after anesthesia induction, immediately after gas insufflation, 10th minute of the ERCP procedure,20th minute of the ERCP procedure,immediately after completion of the ERCP procedure |
Countries
Turkey (Türkiye)